Editorials Influence of pharmaceutical funding on the conclusions of meta-analyses BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39381.655845.BE (Published 06 December 2007) Cite this as: BMJ 2007;335:1167 Article Related content Metrics Responses Peer review Related articles Research Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study Published: 06 December 2007; BMJ 335 doi:10.1136/bmj.39376.447211.BE RESEARCH Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study Published: 16 November 2007; BMJ doi:10.1136/bmj.39376.447211.BE See more Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds BMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518 Semaglutide’s CVD indication could cost US Medicare $145bn extra a year BMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878 Semaglutide: UK regulator approves drug for prevention of cardiovascular events BMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660 Why India is failing to track heatstroke fatalities properly BMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437 Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rules BMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424 Cited by... Preferential publication of editorial board members in medical specialty journalsAbstract Fulltext PDF
